Mechanisms of disease: Molecular genetics of childhood thyroid cancers

Nature Clinical Practice Endocrinology and Metabolism

Volumn 3, Issue 5, 2007, Pages 422-429

  Yamashita, Shunichi ^a,b,d   Saenko, Vladimir ^c  

^a Department of International Health and Radiation Research ^*  (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

Author keywords

Childhood thyroid cancer; Molecular genetics; Papillary thyroid carcinoma; Radiation

Indexed keywords

A KINASE ANCHOR PROTEIN 9; B RAF KINASE; NEUROTROPHIC TYROSINE KINASE RECEPTOR 1; ONCOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P53; PROTEIN RET; RAS PROTEIN; TRANSCRIPTION FACTOR PAX8; TUMOR PROTEIN; UNCLASSIFIED DRUG;

CANCER DIAGNOSIS; CARCINOGENESIS; CHERNOBYL ACCIDENT; CHILDHOOD CANCER; ENVIRONMENTAL RADIOACTIVITY; ENZYME ACTIVATION; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; ONCOGENE; PAPILLARY CARCINOMA; POINT MUTATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THYROID CANCER; TUMOR GENE;

ADENOCARCINOMA, PAPILLARY; CHILD; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; POLYMORPHISM, GENETIC; THYROID NEOPLASMS;

EID: 34247500375     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0499     Document Type: Review

References (67)

1. Mettler FA Jr et al. (1992) Thyroid nodules in the population living around Chernobyl. JAMA 268: 616-619
2. Wartofsky L (2000) The thyroid nodule. In Thyroid Cancer: a Comprehensive Guide to Clinical Management, 3-7 (Ed. Wartofsky L) Totowa: Humana Press
3. Demidchik YE et al. (2006) Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus. Ann Surg 243: 525-532
4. Ron E et al. (1995) Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141: 259-277
5. Shibata Y et al. (2001) 15 years after Chernobyl: new evidence of thyroid cancer. Lancet 358: 1965-1966
6. 131I in childhood. J Natl Cancer Inst 97: 724-732
7. DeLellis RA et al. (Eds; 2004) Pathology and Genetics of Tumors of Endocrine Organs. In World Health Organization Classification of Tumors, 49-133 (Eds Kleihues P and Sobin LH ) Lyon: International Agency for Research on Cancer Press
8. Furmanchuk AW et al. (1992) Pathomorphological findings in thyroid cancers of children from the Republic of Belarus: a study of 86 cases occurring between 1986 ('post-Chernobyl') and 1991. Histopathology 21: 401-408
9. Shirahige Y et al. (1998) Childhood thyroid cancer: comparison of Japan and Belarus. Endocr J 45: 203-209
10. Williams ED et al. (2004) Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness. Br J Cancer 90: 2219-2224
11. Nikiforov YE et al. (2001) Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior. Am J Surg Pathol 25: 1478-1484
12. Rosai J (2004) Poorly differentiated thyroid carcinoma: introduction to the issue, its landmarks, and clinical impact. Endocr Pathol 15: 293-296
13. Harach HR et al. (1995) Childhood thyroid cancer in England and Wales. Br J Cancer 72: 777-783
14. Nikiforov Y et al. (1994) Pediatric thyroid cancer after the Chernobyl disaster: pathomorphologic study of 84 cases (1991-1992) from the Republic of Belarus. Cancer 74: 748-766
15. Nikiforov YE et al. (1999) Pathomorphology of thyroid gland lesions associated with radiation exposure: the Chernobyl experience and review of the literature. Adv Anat Pathol 6: 78-91
16. Rabes HM et al. (2000) Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-Chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications. Clin Cancer Res 6: 1093-1103
17. Nikiforov YE (2002) RET/PTC rearrangement in thyroid tumors. Endocr Pathol 13: 3-16
18. Arighi E et al. (2005) RET tyrosine kinase signaling in development and cancer. Cytokine Growth Factor Rev 16: 441-467
19. Nikiforov YE et al. (1997) Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 57: 1690-1694
20. Thomas GA et al. (1999) High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab 84: 4232-4238
21. Fenton CL et al. (2000) The RET/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. J Clin Endocrinol Metab 85: 1170-1175
22. Sugg SL et al. (1998) Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metab 83: 4116-4122
23. Nakazawa T et al. (2005) RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan). Cancer 104: 943-951
24. Basolo F et al. (2002) Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tallcell variant of papillary thyroid carcinoma. Am J Pathol 160: 247-254
25. Powell DJ Jr et al. (1998) The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. Cancer Res 58: 5523-5528
26. Jhiang SM et al. (1996) Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137: 375-378
27. Ciampi R et al. (2005) Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J Clin Invest 115: 94-101
28. Collins BJ et al. (2002) RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions. J Clin Endocrinol Metab 87: 3941-3946
29. Powell JG et al. (2004) The PAX8/PPARγ fusion oncoprotein transforms immortalized human thyrocytes through a mechanism probably involving wild-type PPARγ inhibition. Oncogene 23: 3634-3641
30. Castro P et al. (2005) A subset of the follicular variant of papillary thyroid carcinoma harbors the PAX8-PPARγ translocation. Int J Surg Pathol 13: 235-238
31. Marques AR et al. (2002) Expression of PAX8-PPARγ1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 87: 3947-3952
32. Suchy B et al. (1998) Absence of ras and p53 mutations in thyroid carcinomas of children after Chernobyl in contrast to adult thyroid tumours. Br J Cancer 77: 952-955
33. Fenton C et al. (1999) Ras mutations are uncommon in sporadic thyroid cancer in children and young adults. J Endocrinol Invest 22: 781-789
34. Meinkoth JL (2004) Biology of RAS in thyroid cells. Cancer Treat Res 122: 131-148
35. Nikiforova MN et al. (2003) RAS point mutations and PAX8-PPARγ rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88: 2318-2326
36. Sobrinho-Simoes M et al. (2005) Molecular pathology of well-differentiated thyroid carcinomas. Virchows Arch 447: 787-793
37. Lima J et al. (2004) BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. J Clin Endocrinol Metab 89: 4267-4271
38. Kumagai A et al. (2004) Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas. J Clin Endocrinol Metab 89: 4280-4284
39. Penko K et al. (2005) BRAF mutations are uncommon in papillary thyroid cancer of young patients. Thyroid 15: 320-325
40. Powell N et al. (2005) Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure. J Pathol 205: 558-564
41. Rosenbaum E et al. (2005) Mutational activation of BRAF is not a major event in sporadic childhood papillary thyroid carcinoma. Mod Pathol 18: 898-902
42. Nikiforova MN et al. (2004) Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas. Cancer Lett 209: 1-6
43. Xing M (2005) BRAF mutation in thyroid cancer. Endocr Relat Cancer 12: 245-262
44. Waldmann V et al. (1997) Absence of Gs? gene mutations in childhood thyroid tumors after Chernobyl in contrast to sporadic adult thyroid neoplasia. Cancer Res 57: 2358-2361
45. Hillebrandt S et al. (1996) Mutations in the p53 tumour suppressor gene in thyroid tumours of children from areas contaminated by the Chernobyl accident. Int J Radiat Biol 69: 39-45
46. Nikiforov Y et al. (1996) Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiation tumorigenesis. J Clin Endocrinol Metab 81: 9-14
47. Smida J et al. (1997) p53 mutations in childhood thyroid tumours from Belarus and in thyroid tumours without radiation history. Int J Cancer 73: 802-807
48. Nikiforova MN et al. (2000) Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science 290: 138-141
49. Hrafnkelsson J et al. (1989) Papillary thyroid carcinoma in Iceland. A study of the occurrence in families and the coexistence of other primary tumours. Acta Oncol 28: 785-788
50. Stoffer SS et al. (1986) Familial papillary carcinoma of the thyroid. Am J Med Genet 25: 775-782
51. Loh KC (1997) Familial nonmedullary thyroid carcinoma: a meta-review of case series. Thyroid 7: 107-113
52. Momani MS et al. (2004) Familial concordance of thyroid and other head and neck tumors in an irradiated cohort: analysis of contributing factors J Clin Endocrinol Metab 89: 2185-2191
53. Ron E et al. (1991) Familial nonmedullary thyroid cancer. Oncology 48: 309-311
54. Goldgar DE et al. (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86: 1600-1608
55. Pal T et al. (2001) Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study. J Clin Endocrinol Metab 86: 5307-5312
56. Hishinuma A et al. (2005) High incidence of thyroid cancer in long-standing goiters with thyroglobulin mutations. Thyroid 15: 1079-1084
57. Perkel VS et al. (1988) Radiation-induced thyroid neoplasms: evidence for familial susceptibility factors. J Clin Endocrinol Metab 66: 1316-1322
58. Ito T et al. (1993) In vitro irradiation is able to cause RET oncogene rearrangement. Cancer Res 53: 2940-2943
59. Caudill CM et al. (2005) Dose-dependent generation of RET/PTC in human thyroid cells after in vitro exposure to γ-radiation: a model of carcinogenic chromosomal rearrangement induced by ionizing radiation. J Clin Endocrinol Metab 90: 2364-2369
60. Mizuno T et al. (2000) Preferential induction of RET/PTC1 rearrangement by X-ray irradiation. Oncogene 19: 438-443
61. Bongarzone I et al. (1997) Comparison of the breakpoint regions of ELE1 and RET genes involved in the generation of RET/PTC3 oncogene in sporadic and in radiation-associated papillary thyroid carcinomas. Genomics 42: 252-259
62. Klugbauer S et al. (2001) RET rearrangements in radiation-induced papillary thyroid carcinomas: high prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes. Genomics 73: 149-160
63. Nikiforov YE et al. (1999) Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE1 and RET genes in radiation-induced thyroid carcinomas. Oncogene 18: 6330-6334
64. Stephens LA et al. (2005) Investigation of loss of heterozygosity and SNP frequencies in the RET gene in papillary thyroid carcinoma. Thyroid 15: 100-104
65. Rogounovitch TI et al. (2006) TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer. Oncol Rep 15: 949-956
66. Saad AG et al. (2006) Proliferative activity of human thyroid cells in various age groups and its correlation with the risk of thyroid cancer after radiation exposure. J Clin Endocrinol Metab 91: 2672-2677
67. Kondo T et al. (2006) Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6: 292-306